admin
Business Wire
  • January 19, 2022

Iterative Scopes Announces $150 Million Series B to Advance AI-Driven Precision Medicine for Gastroenterology

Iterative Scopes Announces $150 Million Series B to Advance AI-Driven Precision Medicine for Gastroenterology
Related Stories

Press Releases

  • April 28, 2022
Iterative Scopes Announces the Acquisition of Clinical Research Strategy Group and Precision Research
Read more

Press Releases

  • February 8, 2022
Iterative Scopes Announces AI-Driven Data Sharing Agreement with Pfizer to Advance IBD Clinical Trials
Read more

Press Releases

  • February 11, 2021
Iterative Scopes Announces Partnership with Eli Lilly and Company to Advance AI Applications for Inflammatory Bowel Disease (IBD) Clinical Trials
Read more
Company
Newsletter
Follow us

© 2024 Iterative Health. All rights reserved